Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
clinical trials
drugs
7
×
fda
7
×
life sciences
national blog main
new york blog main
new york top stories
7
×
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
national top stories
san diego blog main
san diego top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
investing
startups
astrazeneca
cancer
deals
eli lilly
pfizer
teva pharmaceutical
abbvie
boston
What
fda
bio
drug
roundup
companies
decades
drugs
make
week
ago
ahead
alnylam
alzheimer’s
annual
approval
approve
approved
arguments
asco
assessed
attention
awaits
babies
big
biological
biotech
biotechs
birth
born
branded
breastfeed
choices
chose
class
close
commercialized
commissioner
communities
company
competitors
Language
Current search:
fda
×
biotech
×
drugs
×
" new york top stories "
×
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision